People with disabilities have high rates of chronic health conditions and often require
complex medication regimens to manage their health. Approximately 20–50% of people with …

Objective: To assess polypharmacy and related medication aspects in Middle-European
rheumatoid arthritis (RA) patients, and to discuss the results in view of a systematic literature …

Background Systemic mastocytosis (SM) is a rare clonal neoplasm driven by KIT D816V and
other mutations. Data were collected from the patient perspective on disease burden and …

Polypharmacy is increasingly common in rheumatology due to the complex nature of
managing chronic autoimmune diseases. To date there has been limited research into the …

Background Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are chronic, progressive
inflammatory diseases that can be accompanied by other diseases. In recent years, with the …

Rheumatoid arthritis is an autoimmune inflammatory disease with progressive degradation
of cartilage and joints. Additionally, gastric ulcer affects many patients who make prolonged …

In recent years, several changes have occurred in the management of chronic
immunological conditions with the emerging use of targeted therapies. This two-phase cross …

Objectives Polypharmacy, drug-drug interactions (DDI) and related adverse drug reaction
(ADR) are understudied in SSc. The aim of this work was to determine the prevalence and …

Background: While the use of the term “quality” in industry relates to the basic idea of making
processes measurable and standardizing processes, medicine focuses on achieving health …

Objective This study aimed to identify factors associated with polypharmacy, including social
aspects, among patients with rheumatoid arthritis. Methods We conducted this single-centre …